Recently, a tumor study observed that DNA methylation participates in shaping tumor-reactive and bystander CD8+ tumor-infiltrating lymphocytes which refers to a subpopulation of T cells recognizing and destroying tumor cells specifically and recognizing a wide range of epitopes unrelated to the tumor, respectively (78). The gene discussed is CD8A; the disease is neoplasm.